| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 449,085 | 252,009 | 248,611 | 268,402 | | Cost of Revenue | (228) | 94,189 |
-
| 35,708 | | | Gross Profit | 449,313 | 157,820 | 248,611 | 232,694 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 160,494 | 55,072 | 162,519 | 122,733 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 20,364 | 12,762 | 12,562 | 12,266 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 95,303 | 89,986 | 73,530 | 97,695 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 17,513 | (596) | (12,739) | (56,059) | | Earnings Before Interest And Taxes | 112,816 | 89,390 | 60,791 | 20,217 | | Interest Expense | 1,034 | 1,051 | 799 | 740 | | Income Before Tax | 111,782 | 88,339 | 59,992 | 19,477 | | Income Tax Expense | 31,109 | 24,212 | 8,929 | 9,828 | | Minority Interest |
-
|
-
|
-
| (21,419) | | | | Net Income From Continuing Ops | 13,308 | 64,127 | 51,063 | 9,649 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 13,308 | 64,127 | 51,063 | 9,649 | | Preferred Stock And Other Adjustments | 39,419 | (22,556) | (16,863) |
-
| | | Net Income Applicable To Common Shares | $52,727 | $41,571 | $34,200 | $9,649 |
|
0.16% Nasdaq 
Income Statement
